Target intelligence / Profile preview

C-type lectin receptor (CLR)

Target
CLR
Molecular classification
Receptor, Pattern recognition receptor (PRR), Transmembrane protein, soluble protein, C-type lectin domain-containing protein, Subfamilies: Dectin family, NK cell receptor group, DC-SIGN subset, Group II/V C-type lectins
01

Overview

C-type lectin receptor refers to a large family of immune receptors characterized by the presence of one or more C-type lectin-like domains (typically carbohydrate-binding domains requiring calcium). These receptors are expressed predominantly on myeloid cells such as monocytes, macrophages, dendritic cells, and some lymphocyte subsets, including NK cells. Their primary biological role is to sense and bind pathogen-associated carbohydrate structures (glycans), as well as endogenous molecules released during cell damage, thereby functioning as pattern recognition receptors (PRRs) essential for innate and adaptive immune response. Upon ligand binding, CLRs trigger signaling pathways that regulate cytokine production, phagocytosis, antigen uptake and presentation, and may modulate T cell differentiation based on the type of ligand engaged. The CLR family encompasses many individual receptors (e.g., Dectin-1, Mincle, DC-SIGN, CLEC9A, LOX-1) with distinct functions and regulatory profiles, making them diverse and multifunctional mediators of immunity, inflammation, and tissue homeostasis. Dysfunction or aberrant regulation of CLR signaling is implicated in infection, inflammation, autoimmunity, allergy, and cancer, underscoring their therapeutic relevance.

Other names
C-type lectin-like receptorCTLRCLECPattern recognition receptorPRRLectin receptor
02

Mechanism of action

Modulation of innate immune signaling (activation or inhibition) Triggering phagocytosis / antigen presentation Regulating cytokine production and T cell differentiation Interference with pathogen recognition or adhesion

03

Biological functions

Pathogen recognitionImmune response regulationAntigen presentationCell-cell adhesionScavenger receptor activitySensing cell death and stress signalsPhagocytosisCytokine regulation
04

Disease associations

InfectionInflammationCancerAllergy and hypersensitivityAutoimmune diseaseOther (hematopoiesis, homeostasis)
05

Safety considerations

Potential for immune dysregulationRisk of allergenic responsesOff-target effectsAutoimmune activation
06

Interacting drugs

Immunotherapies targeting dendritic cells, myeloid cells

1 more in the full profile.

07

Biomarkers

Expression level of individual CLRsSoluble CLR fragmentsCytokine/chemokine profile following CLR engagement

Beyond the preview

Go deeper on C-type lectin receptor (CLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin receptor (CLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call